Millennium reports 3% Fulgent Genetics stake
Fulgent Genetics, Inc. received an amended Schedule 13G/A (Amendment No. 4) reporting institutional ownership of its common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Fulgent Genetics, Inc. received an amended Schedule 13G/A (Amendment No. 4) reporting institutional ownership of its common stock. Investment entities including Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander report beneficial ownership of about 3.0% of the common stock, including 939,375 shares with shared voting and dispositive power for several reporting persons and 918,503 shares for Integrated Core Strategies. The filers certify the shares were not acquired to change or influence control of Fulgent Genetics.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in Fulgent Genetics (FLGT) does Millennium report in this Schedule 13G/A?
Who are the reporting persons in the Fulgent Genetics (FLGT) Schedule 13G/A Amendment No. 4?
Does the Fulgent Genetics (FLGT) Schedule 13G/A indicate an intent to influence control of the company?
What percentage of Fulgent Genetics (FLGT) does Israel A. Englander report beneficially owning?
What is the relevant event date for the Fulgent Genetics (FLGT) Schedule 13G/A ownership information?
AI-generated analysis. How Rhea-AI works. Not financial advice.